Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Artelo Biosciences successfully closed an $11 million private placement by issuing common shares and warrants, with proceeds aimed at working capital, general corporate purposes, and debt repayment. The potential further proceeds of approximately $20.4 million could be realized if warrants are fully exercised. This financing enhances the company's …